Aeluma signs CHIPS letter of intent for up to $30 million in U.S. R&D funding
Aeluma, Inc. announced on July 29, 2026 that it signed a letter of intent for up to $30 million of proposed CHIPS and Science Act funding from the U.S. Department of Commerce to support R&D of its non-InP photonics platform. The award remains subject to due diligence, government approvals and definitive award documents, and in connection with final documents Aeluma would issue equity securities to the Department of Commerce with a value equal to the award amount, which may dilute existing shareholders.
Key points
- Letter of intent for up to $30 million under the CHIPS and Science Act, dated July 29, 2026
- Part of the award is to be funded up front, with the remainder paid on a milestone basis
- Aeluma would issue equity securities to the U.S. Department of Commerce with an aggregate value equal to the award amount in connection with final documents
- Award is not final and depends on due diligence, required approvals and execution of definitive award documents
The filing
Written by AI on Nov 9, 2026, 11:43 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 29, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.